TA126 Rheumatoid arthritis (refractory) - rituximab: understanding NICE guidance

The summary of the key recommendations of the technology appraisal on Rheumatoid arthritis (refractory) - rituximab. It is written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets or any other suitable publication.